고식적 항암화학요법으로 완치가 된 진행성 식도암 환자 1예

A Case of Complete Remission to Advanced Esophageal Cancer by a Palliative Chemotherapy

  • 탁대현 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 문희석 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 정현용 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 성재규 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 강선형 (충남대학교 의학전문대학원 내과학교실, 소화기내과)
  • Dae Hyun Tak (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Hee Seok Moon (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Hyun Yong Jeong (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Jae Kyu Sung (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Sun Hyung Kang (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine)
  • 투고 : 2014.12.01
  • 심사 : 2014.12.12
  • 발행 : 2014.12.31

초록

식도암은 다른 암종에 비해서 예후가 좋지 못하며, 최근 외과적 수술의 근치적 절제율의 발달과 항암화학방사선동시요법이 효과적이라는 보고들은 있으나, 진행성 식도암의 경우에 있어서는 부분관해에 이르는 것이 대부분이며, 한계가 있는 것이 사실이다. 저자들은 80세 남자가 한 달 전부터 발생한 연하곤란을 주소로 내원하였으며, 식도암 및 암종의 주기관지로의 함입, 다발성의 전이성 림프절 비대를 보여 진행성 식도암으로 진단을 받았다. 그러나 환자가 고령이라는 점, 전신상태가 좋지 못한 점, 식도암이 주기관지까지 함입되어 있어 방사선치료 후 누공이 발생할 가능성 등을 염두하여 고식적인 항암화학요법만을 시행하였으나, 총 6차에 걸친 항암화학요법 후에 완전 관해에 이른 드문 증례를 경험하였다.

Esophageal cancer has a poor prognosis, because the progression rate is faster compared to that of other cancers, Up to 30-40% of cases are inoperable at diagnosis, and most cases occur in the elderly. By this time, surgery has been regarded as the treatment of choice in patients suffering esophageal cancer and recent improvements in surgical techniques and perioperative management have significantly increased the resection rate and reduced the operative mortality. And Although the combination of chemotherapy and radiation therapy has been reported to be an effective treatment for esophageal cancer, most cases show only partial remission. Moreover, radiation therapy alone or chemotherapy alone has limited efficacy. We report a rare case of an 80-year-old man who presented with a chief complaint of dysphasia and was diagnosed with advanced esophageal cancer, with a review of the literature. Considering his advanced age, generally poor performance status, and the risk of fistula development after radiation therapy due to indentation of esophageal cancer into the main bronchus, palliative, rather than therapeutic, chemotherapy was performed, and complete remission was obtained.

키워드

참고문헌

  1. Fink U, Stein HJ, Wilke H, Rober JD, Siewert JR. Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995;19:198-204.
  2. Feliu J, Baron MG, Giron CG, Espinosa E, et al. Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. Am J Clin Oncol 1996;19:577-580.
  3. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. Br J Surg 1980;67:381-390.
  4. Ferguson MK, Martin TR, Reeder LB, Olak J. Mortality after esophagectomy: risk factor analysis. World J Surg 1997;21:599-604.
  5. Kelsen D, Hilaris B, Coonley C. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 1983;75:645-650.
  6. Jeong SH, Im YH, Kang YK, et al. Neoadjuvant chemotherapy with cisplatin, etoposide and 5-fluorouracil (PEF) followed by surgery in patients with locally advanced esophageal cancer: A pilot study. Korean J Med 1996;51:520-528.
  7. Lee EJ, Lee KH, Kim SM, et al. Effects and prognostic factors of combined chemotherapy and radiotherapy in treatment of patients with esophageal cancer. Korean J Gastroenterol 2000;35:1-8.
  8. Reed CE. Surgical management of esophageal carcinoma. Oncologist 1999;4:95-105.
  9. Chak A, Canto M, Gerdes H, et al. Prognosis of esophageal cancers preoperatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. Gastrointest Endosc 1995;42:501-506.
  10. Fockens P, Kisman K, Merkus MP, et al. The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg 1998;186:17-23.
  11. Mauer A, Haraf D, Ferguson M, et al. Docetaxel-based combined modality therapy for locally advanced carcinoma of the esophagus and gastric cardia. Proc Ann Meet Am soc Clin Oncol 2000;19:246.
  12. Heath EJ, Urba S, Marshall J, et al. Phase II trial of docetaxel chemotherapy in patient with incurable adenocarcinoma of the esophagus. Invest New Drugs 2002;20:95-99.
  13. Woo IS, Jung KH, Park YL, et al. 5-Fluorouracil and cisplatin (FP) combination chemotherapy in advanced esophageal cancer. Korean Cancer Assoc 1996;28:835-841.
  14. Forsella FV, Lee JS, Murphy WK, et al. Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer. J Clin Oncol 1994;12:1238-1244.
  15. Laack E, Andritzky B, Durk H, et al. Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study. Onkologie 2005;28:647-650.